Who Paid My Doc
Proclaim
Device Neuromodulation
PDI 05415067031426
General payments
$168,276
Research payments
$2,382,742
Through program year 2025, $168,276 in general payments and $2,382,742 in research payments were reported against Proclaim (Neuromodulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $5,895 | 1 |
| 2024 | General | $34,565 | 1,158 |
| 2023 | General | $74,107 | 2,397 |
| 2023 | Research | $523,190 | 183 |
| 2022 | General | $59,604 | 2,341 |
| 2022 | Research | $1,853,658 | 286 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 51 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
5,896 general · 470 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.